| abstract |
The present invention relates to compounds or pharmaceutically acceptable polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. A pharmaceutical composition comprising an effective amount of a compound of Formula I, Formula II, Formula III, Formula IV, Formula V, Formula VI, Formula VII, Formula VIII, Formula IX, or Formula X, and treatment of a fungal infection can be administered orally, buccal, rectal, topical, transdermal, transmucosal, lozenge, spray, intravenous, oral solution, buccal mucosal layer ), parenteral administration, syrup or injection. The composition may be used for the treatment of fungal infections. |